Clinical and epidemiological aspects of cardiomyopathies: a critical review of current knowledge

Mario Sangiorgi1

  • 1Department of Internal Medicine, University of Tor Vergata, Rome, Italy

Insights

This review clarifies cardiomyopathies (CM), defining them as direct myocardial injuries, not consequences of other conditions. It proposes a classification based on morpho-functional alterations and etiology for better understanding and diagnosis.

Area of Science:

  • Cardiology
  • Pathology
  • Genetics

Background:

  • Current definitions of cardiomyopathies (CM) are often confused by terms like ischemic or hypertensive CM.
  • Myocardial injury encompasses macroscopic, subcellular, ultrastructural, and molecular damage, including genetic origins.
  • CM manifestations include ventricular dysfunction and bioelectric defects like arrhythmias.

Purpose of the Study:

  • To critically review and refine the definition and classification of cardiomyopathies.
  • To propose a classification based on morpho-functional alterations and etiology.
  • To clarify the concept of myocardial injury in the context of CM.

Main Methods:

  • Critical review of existing literature and classifications of cardiomyopathies.
  • Analysis of the concept of myocardial injury, including its various levels of manifestation.
  • Synthesis of etiopathogenetic, pathophysiological, and clinical features for classification.

Main Results:

  • Cardiomyopathies are defined as direct myocardial injuries, distinct from ischemic or overload conditions.
  • Proposed classification includes dilated (hypokinetic), hypertrophic, restrictive, and arrhythmogenic CM, with mixed forms.
  • Distinction between specific (known cause) and primary/idiopathic CM (including genetic forms) is maintained.

Conclusions:

  • A refined definition and classification of cardiomyopathies are essential for accurate diagnosis and understanding.
  • Recognizing myocardial injury as the core pathology, at multiple levels, is crucial.
  • This framework aims to encompass current knowledge for a comprehensive clinical-epidemiological setting.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...